Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
The Prostate|July 22, 2014
Expression of phosphorylated-mTOR during the development of prostate cancerSarah I M Sutherland, Ruth Pe Benito, Susan M Henshall, et al.
The Journal of Pain|July 21, 2019
Quantification of Small Fiber Neuropathy in Chemotherapy-Treated PatientsHannah C Timmins, Tiffany Li, Matthew C Kiernan, et al.
BJUI Compass|January 2, 2025
Investigating the prognostic utility of GSTP1 promoter methylation in prostate cancerRuth Pidsley, Dilys Lam, Wenjia Qu, et al.
Cellular Immunology|June 11, 2023
CD300f signalling induces inhibitory human monocytes/macrophagesSarah I M Sutherland, Xinsheng Ju, Pablo A Silveira, et al.
Critical Reviews in Oncology/Hematology|October 21, 2015
Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trialsAdnan M Nagrial, Venessa T Chin, Katrin M Sjoquist, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 28, 2022
Proteomic characterisation of prostate cancer intercellular communication reveals cell type-selective signalling and TMSB4X-dependent fibroblast reprogrammingYunjian Wu, Kimberley C Clark, Elizabeth V Nguyen, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|May 26, 2025
The cost-utility of targeted germline BRCA testing in localized prostate cancer followed by cascade testing first-degree relatives with pathogenic variantsSrinivas Teppala, Paul Scuffham, Kim Edmunds, et al.
Cancers|April 12, 2022
Harnessing the Heterogeneity of Prostate Cancer for Target Discovery Using Patient-Derived ExplantsMargaret M Centenera, Andrew D Vincent, Max Moldovan, et al.
The Medical Journal of Australia|August 27, 2009
Second opinions in oncology: the experiences of patients attending the Sydney Cancer CentreMartin H N Tattersall, Rachel F Dear, Jesse Jansen, et al.
Pageof 13